Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
24-1/2
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
24-1/2
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #719
advertisement
Ocular Surface
25
Showing records 1 to 25 |
Display all abstracts in
Ocular Surface
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Grainger RM
Ocular Surface
2023; 29: 423-431
109603
The versatile roles of lumican in eye diseases: A review
Tsui MC
Ocular Surface
2023; 29: 388-397
109440
Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway
Yang Y
Ocular Surface
2023; 29: 272-278
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
López-Cano JJ
Ocular Surface
2023; 29: 314-330
109440
Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway
Shi M
Ocular Surface
2023; 29: 272-278
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
González-Cela-Casamayor MA
Ocular Surface
2023; 29: 314-330
109603
The versatile roles of lumican in eye diseases: A review
Liu HY
Ocular Surface
2023; 29: 388-397
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Lauderdale JD
Ocular Surface
2023; 29: 423-431
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
Andrés-Guerrero V
Ocular Surface
2023; 29: 314-330
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Collins JL
Ocular Surface
2023; 29: 423-431
109603
The versatile roles of lumican in eye diseases: A review
Chu HS
Ocular Surface
2023; 29: 388-397
109440
Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway
Li G
Ocular Surface
2023; 29: 272-278
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
Vicario-de-la-Torre M
Ocular Surface
2023; 29: 314-330
109440
Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway
Shen L
Ocular Surface
2023; 29: 272-278
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Trout KL
Ocular Surface
2023; 29: 423-431
109603
The versatile roles of lumican in eye diseases: A review
Chen WL; Hu FR
Ocular Surface
2023; 29: 388-397
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
McCullen Krantz S
Ocular Surface
2023; 29: 423-431
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
Benítez-Del-Castillo JM
Ocular Surface
2023; 29: 314-330
109440
Novel discovery of a lymphatic bridge connecting Schlemm's canal to limbal and conjunctival lymphatic pathway
Chen L
Ocular Surface
2023; 29: 272-278
109603
The versatile roles of lumican in eye diseases: A review
Kao WW
Ocular Surface
2023; 29: 388-397
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
Herrero-Vanrell R
Ocular Surface
2023; 29: 314-330
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Wolfe SS
Ocular Surface
2023; 29: 423-431
109603
The versatile roles of lumican in eye diseases: A review
Wang IJ
Ocular Surface
2023; 29: 388-397
109448
Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond
Netland PA
Ocular Surface
2023; 29: 423-431
109511
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
Molina-Martínez IT
Ocular Surface
2023; 29: 314-330
Issue
24-1/2
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept